Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.62 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.59 |
| ▸ | CDK1 | P06493 | 3/20 | 0.59 |
| ▸ | CDK4 | P11802 | 3/20 | 0.59 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.59 |
| ▸ | CCND1 | P24385 | 3/20 | 0.59 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.59 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.59 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.58 |
| ▸ | FBP1 | P09467 | 1/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.57 |
| ▸ | NQO2 | P16083 | 1/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.56 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.56 |
| ▸ | TUBB | P07437 | 1/20 | 0.56 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25259513 | 1.00 | RELA (0.62) | RELACCNB2CDK1CDK4CCNB1 | |
| SCHEMBL29897304 | 1.00 | RELA (0.62) | RELACCNB2CDK1CDK4CCNB1 | |
| SCHEMBL1308087 | 1.00 | RELA (0.62) | RELACCNB2CDK1CDK4CCNB1 | |
| SCHEMBL31317665 | 0.84 | RELA (0.84) | RELANFE2L2CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL23158820 | 0.84 | RELA (0.84) | RELANFE2L2CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL700055 | 0.84 | RELA (0.84) | RELANFE2L2CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL700056 | 0.84 | RELA (0.84) | RELANFE2L2CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL7592867 | 0.83 | RELA (0.70) | RELANFE2L2CYP1A1CYP1A2CYP1B1 | |
| Cinnamaldehyde SCHEMBL29125665 | 0.83 | ALDH1A1 (0.69) | RELACCNB2CDK1CDK4CCNB1 | |
| SCHEMBL7592868 | 0.83 | RELA (0.70) | RELANFE2L2CYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| EP-4464696-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | Konkuk University Industrial Cooperation Corp. (KR) | 2024-11-20 | — | — | EP | claimed |
| CN-118164997-A | Sesquiterpene lactone scaberol C thioether derivative, and preparation method and application thereof | 沈阳药科大学 | 2024-06-11 | — | — | CN | claimed |
| CN-118164996-A | Sesquiterpene lactone scaberol C selenoether derivative, preparation method and application thereof | 沈阳药科大学 | 2024-06-11 | — | — | CN | claimed |
| CN-118164998-A | Sesquiterpene lactone scaberol C dithio carbamate derivative and preparation method and application thereof | 沈阳药科大学 | 2024-06-11 | — | — | CN | claimed |
| US-20230365742-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2023-11-16 | — | — | US | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| US-11458049-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-04 | — | — | US | claimed |
| CN-114272323-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of lactating women | 华子昂 | 2022-04-05 | — | — | CN | claimed |
| CN-109020794-A | The preparation method of 3- methoxycinnamic aldehyde | 上海华堇生物技术有限责任公司 | 2018-12-18 | — | — | CN | claimed |
| WO-2018048852-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-15 | — | — | WO | claimed |
| US-20180064588-A1 | Absorbent Articles Including Perfume and Cyclodextrins | THE PROCTER & GAMBLE COMPANY | 2018-03-08 | — | — | US | claimed |
| CN-102992981-A | Industrial preparation method of 3-methoxycinnamaldehyde | HUBEI YUANCHENG PHARMACEUTICAL | 2013-03-27 | — | — | CN | claimed |
| US-20100292158-A1 | Compositions and Methods for Enhanced Pharmacological Activity of Compositions Comprising Peptide Drug Substances | IMMUPHARMA SA (FRANCE) | 2010-11-18 | — | — | US | claimed |
| US-7671029-B2 | Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances | IMMUPHARMA SA (FR) | 2010-03-02 | — | — | US | claimed |
| US-7321044-B2 | Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens | SCHERING AKTIENGESELLSCHAFT (DE) | 2008-01-22 | — | — | US | claimed |
| CN-1602298-A | Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens | SCHERING AG (DE) | 2005-03-30 | — | — | CN | claimed |
| US-20040186058-A1 | Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances | UREKA SARL (FR) | 2004-09-23 | — | — | US | claimed |
| US-20030162974-A1 | Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens | SCHERING AG (DE) | 2003-08-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162974-A1 | Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens | CYP19A1, HSD17B11, SULT1E1 | RELA 1375/4885CCNB2 670/4885CDK1 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.